Alnylam Pharmaceuticals
Price & Volume
Stats
See moreOpen | $233.38 |
Previous Close | $236.56 |
Day Range | $232.62-$234.80 |
52W Range | $197.81-$495.55 |
Market Cap | $31.9B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $4.8B |
Revenue Growth (YoY) | 66.9% |
Gross Profit (12 Mos) | $3.8B |
Diluted EPS | $5.71 |
News
See moreYahoo Finance • 6 hours ago
Alnylam drops as AstraZeneca posts full trial results for failed heart drug
Yahoo Finance • 6 hours ago
Alnylam stock drops on rival heart trial: Why analysts see core business safe
Yahoo Finance • 2 days ago
Moderna Stock Carries A Market Value Its Revenue Does Not Support
Yahoo Finance • 3 days ago
BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |